- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
EUJ.5: 15 residues within 4Å:- Chain A: Y.47, K.55, K.59, R.61, K.62, C.64, K.65, L.311, L.314, L.315, R.318, S.319, R.322, Y.355, R.403
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:L.311, A:L.315
- Hydrogen bonds: A:K.55, A:C.64, A:K.65, A:R.318, A:S.319, A:S.319, A:R.322, A:Y.355
- Salt bridges: A:K.55, A:K.59, A:R.61, A:K.65, A:K.65, A:R.318, A:R.318, A:R.322, A:R.403
EUJ.9: 15 residues within 4Å:- Chain B: Y.47, K.55, K.59, R.61, K.62, C.64, K.65, L.311, L.314, L.315, R.318, S.319, R.322, Y.355, R.403
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:L.311, B:L.315
- Hydrogen bonds: B:K.55, B:C.64, B:K.65, B:R.318, B:S.319, B:S.319, B:R.322, B:Y.355
- Salt bridges: B:K.55, B:K.59, B:R.61, B:K.65, B:K.65, B:R.318, B:R.318, B:R.322, B:R.403
EUJ.11: 15 residues within 4Å:- Chain C: Y.47, K.55, K.59, R.61, K.62, C.64, K.65, L.311, L.314, L.315, R.318, S.319, R.322, Y.355, R.403
19 PLIP interactions:19 interactions with chain C- Hydrophobic interactions: C:L.311, C:L.315
- Hydrogen bonds: C:K.55, C:C.64, C:K.65, C:R.318, C:S.319, C:S.319, C:R.322, C:Y.355
- Salt bridges: C:K.55, C:K.59, C:R.61, C:K.65, C:K.65, C:R.318, C:R.318, C:R.322, C:R.403
EUJ.13: 15 residues within 4Å:- Chain D: Y.47, K.55, K.59, R.61, K.62, C.64, K.65, L.311, L.314, L.315, R.318, S.319, R.322, Y.355, R.403
19 PLIP interactions:19 interactions with chain D- Hydrophobic interactions: D:L.311, D:L.315
- Hydrogen bonds: D:K.55, D:C.64, D:K.65, D:R.318, D:S.319, D:S.319, D:R.322, D:Y.355
- Salt bridges: D:K.55, D:K.59, D:R.61, D:K.65, D:K.65, D:R.318, D:R.318, D:R.322, D:R.403
- 4 x A4I: (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate(Non-covalent)
A4I.6: 17 residues within 4Å:- Chain A: L.422, V.425, M.426, C.429, V.432, A.433, Y.436, L.437, S.461, F.465, F.513
- Chain C: Y.499, S.500, S.503, L.504, Y.507, M.508
9 PLIP interactions:5 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:L.422, A:V.425, A:Y.436, A:F.513, C:Y.499, C:Y.499, C:Y.507
- Hydrogen bonds: A:S.461, C:S.500
A4I.10: 17 residues within 4Å:- Chain B: L.422, V.425, M.426, C.429, V.432, A.433, Y.436, L.437, S.461, F.465, F.513
- Chain D: Y.499, S.500, S.503, L.504, Y.507, M.508
9 PLIP interactions:5 interactions with chain B, 4 interactions with chain D- Hydrophobic interactions: B:L.422, B:V.425, B:Y.436, B:F.513, D:Y.499, D:Y.499, D:Y.507
- Hydrogen bonds: B:S.461, D:S.500
A4I.12: 17 residues within 4Å:- Chain B: Y.499, S.500, S.503, L.504, Y.507, M.508
- Chain C: L.422, V.425, M.426, C.429, V.432, A.433, Y.436, L.437, S.461, F.465, F.513
9 PLIP interactions:4 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:Y.499, B:Y.499, B:Y.507, C:L.422, C:V.425, C:Y.436, C:F.513
- Hydrogen bonds: B:S.500, C:S.461
A4I.14: 17 residues within 4Å:- Chain A: Y.499, S.500, S.503, L.504, Y.507, M.508
- Chain D: L.422, V.425, M.426, C.429, V.432, A.433, Y.436, L.437, S.461, F.465, F.513
9 PLIP interactions:5 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:L.422, D:V.425, D:Y.436, D:F.513, A:Y.499, A:Y.499, A:Y.507
- Hydrogen bonds: D:S.461, A:S.500
- 2 x NA: SODIUM ION(Non-functional Binders)
NA.7: 4 residues within 4Å:- Chain A: D.471
- Chain B: D.471
- Chain C: D.471
- Chain D: D.471
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.471
NA.8: 0 residues within 4Å:- (No contacts)
4 PLIP interactions:2 interactions with chain C, 1 interactions with chain B, 1 interactions with chain A- Water bridges: C:G.470, C:G.470, B:G.470, A:G.470
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gan, N. et al., Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P 2 and rapamycin. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-02-02
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
- 4 x A4I: (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gan, N. et al., Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P 2 and rapamycin. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-02-02
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.